Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 701–800 of 1,001
Pathophysiology, Diagnosis, and New Therapeutic Approaches for Ischemic Mitral Regurgitation
Hadjadj, S., Marsit, O., Paradis, J., & Beaudoin, J. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.12.011 · Cited by 16
Stolz, L., Orban, M., Braun, D., Doldi, P. M., Orban, M., Stark, K., Mehr, M., Steffen, J., Löw, K., Hagl, C. M., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01961-5 · Cited by 16
Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?
Zhang, X., Puehler, T., Søndergaard, L., Frank, D., Seoudy, H., Mohammad, B., Müller, O. J., Sellers, S., Meier, D. J., Sathananthan, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123377 · Cited by 16
Simonian, N. T., Liu, H., Pouch, A. M., Gorman, J. H., Gorman, R. C., & Sacks, M. S. (2022) · JTCVS Techniques · doi:10.1016/j.xjtc.2022.09.013 · Cited by 16
Shaer, A. E., Ponce, A. C., Mazur, P. K., Greason, K. L., Arghami, A., Eleid, M. F., Guerrero, M. E., Rihal, C. S., Crestanello, J. A., & Alkhouli, M. A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026236 · Cited by 16
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management
Ilonze, O. J., Free, K., Shinnerl, A., Lewsey, S. C., & Breathett, K. K. (2023) · Heart Failure Clinics · doi:10.1016/j.hfc.2023.02.009 · Cited by 16
Qi, R., Nayar, N. U., & Desai, J. P. (2023) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2023.3310039 · Cited by 16
“The transcatheter mitral-valve repair resulted in a lower rate of patient hospitalization and lower overall mortality within 24 months of follow-up compared to medical therapy alone [15].”
ResultIn Silico Analysis of the MitraClip in a Realistic Human Left Heart Model
Pasta, S. (2023) · Prosthesis · doi:10.3390/prosthesis5030061 · Cited by 16
von Bardeleben, R. S., Khan, M. S., Geyer, M., Friede, T., Butler, J., Diek, M., Heinrich, J., Placzek, M., Ferrari, R., Abraham, W. T., et al. (2024) · Global Cardiology · doi:10.4081/cardio.2024.40 · Cited by 16
Self-citationKim, J. J., Alakbarli, J., Palumbo, M. C., Xie, L. X., Rong, L. Q., Tehrani, N. H., Brouwer, L. R., Devereux, R. B., Wong, S. C., Bergman, G. W., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28147 · Cited by 16
Sauter, M., Patzelt, J., Mezger, M., Nording, H., Reil, J., Saad, M. F., Seizer, P., Schreieck, J., Rosenberger, P., Langer, H. F., et al. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100413 · Cited by 16
Towards safe and efficient preoperative planning of transcatheter mitral valve interventions
Astudillo, P., Beule, M. D., Dambre, J., & Mortier, P. (2019) · Morphologie · doi:10.1016/j.morpho.2019.09.002 · Cited by 16
Kim, J. J., Palumbo, M. C., Khalique, O. K., Rong, L. Q., Sultana, R., Das, M., Jantz, J., Nagata, Y., Devereux, R. B., Wong, S. C., et al. (2019) · Cardiovascular Ultrasound · doi:10.1186/s12947-019-0181-z · Cited by 16
Guha, A., Dey, A. K., Omer, S., Abraham, W. T., Attizzani, G. F., Jneid, H. M., & Addison, D. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.047 · Cited by 16
Self-citationAdvances in the Management of Acute Decompensated Heart Failure
Mitter, S. S., & Pinney, S. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.03.002 · Cited by 16
Asgar, A., Ducharme, A., Pellerin, M., Garceau, P., Basmadjian, A., Bouchard, D., & Bonan, R. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.11.018 · Cited by 10
Doldi, P. M., Brinkmann, I., Orban, M., Stolz, L., Orban, M., Stocker, T. J., Löw, K., Buech, J., Näbauer, M., Illigens, B. M. W., et al. (2021) · Clinical Cardiology · doi:10.1002/clc.23599 · Cited by 16
Giordano, A., Biondi‐Zoccai, G., Finizio, F., Ferraro, P., Denti, P., Rubbio, A. P., Petronio, A. S., Bartorelli, A. L., Mongiardo, A., Felice, F. D., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.08.010 · Cited by 16
Arshad, H. B., Minhas, A. M. K., Khan, S. U., Nasir, K., Rao, N., Thacker, S., Butt, S., Faza, N. N., Little, S. H., von Ballmoos, M. C. W., et al. (2021) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2021.11.016 · Cited by 17
Self-citationRight ventricular function in transcatheter mitral and tricuspid valve edge-to-edge repair
Stolz, L., Doldi, P. M., Weckbach, L. T., Stocker, T. J., Braun, D., Orban, M., Wild, M. G., Hagl, C. M., Maßberg, S., Näbauer, M., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.993618 · Cited by 15
Frazzetto, M., Sanfilippo, C., Costa, G., Scandura, S., Castania, G., Santis, J. D., Sanfilippo, M., Salvo, M. E. D., Uccello, S., Rugiano, G., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144742 · Cited by 15
Unique Aspects of Women's Valvular Heart Diseases: Impact for Diagnosis and Treatment
Powers, A., Lavoie, N., Nezet, E. L., & Clavel, M.-A. A. (2023) · CJC Open · doi:10.1016/j.cjco.2023.10.017 · Cited by 15
“95 However, many patients who are at prohibitive risk for surgery are ineligible for transcatheter MV replacement, owing to their having small LV dimensions, severe mitral annulus calci fi cation, and too-small or too-large mitral annular diameters; thus, such patients are treated medically, which…”
BackgroundTokuda, T., Yamamoto, M., Kagase, A., Shimura, T., Yamaguchi, R., Saji, M., Asami, M., Enta, Y., Nakashima, M., Shirai, S., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035109 · Cited by 15
“1,14 Conversely, the EXPAND (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) and EXPAND G4 registries using the recent version of MitraClip G3–G4 systems have shown that the rate of post-MR ≥2+ decreased to…”
Jawad, M. A., Jones, P. G., Arnold, S. V., Cohen, D. J., Sherrod, C., Khan, M. S., Ikemura, N., Chan, P. S.-F., & Spertus, J. A. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.4470 · Cited by 16
Self-citationAnker, S. D., Friede, T., Butler, J., Talha, K. M., Diek, M., Nosko, A., Placzek, M., Hasenfuss, G. P., Ponikowski, P. P., & Karakas, M. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3574 · Cited by 15
Transition to Advanced Heart Failure: From Identification to Improving Prognosis
Tepetes, N.-I., Kourek, C., Papamichail, A., Xanthopoulos, A. V., Kostakou, P. M., PARASKEVAIDIS, I. A., & Briasoulis, Α. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12030104 · Cited by 15
“…Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) study [65], have demonstrated that transcatheter mitral valve repair leads to significant reductions in hospitalizations and lower all-cause mortality…”
Tsunamoto, H., Yamamoto, M., Kagase, A., Tokuda, T., Sugiura, A., Shimura, T., Murata, A., Yamaguchi, R., Izumi, Y., Saji, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.041 · Cited by 15
Rizik, D. G., Burke, R. F., & Goldstein, J. A. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28439 · Cited by 15
Harb, S. C., Krishnaswamy, A., Kapadia, S. R., & Miyasaka, R. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.11.014 · Cited by 15
Self-citationOver 15 years: the advancement of transcatheter mitral valve repair
Denti, P., Sala, A., Belluschi, I., & Alfieri, O. (2021) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2020-mv-18 · Cited by 15
Indirect Mitral Annuloplasty Using the Carillon Device
Krishnaswamy, A., & Kapadia, S. R. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.576058 · Cited by 15
“1Department of Interventional Cardiology, Cleveland Clinic, Cleveland, OH, United States, 2Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, United States Patients with functional, or secondary, mitral regurgitation (FMR, SMR) often face significant symptoms that lead to functional decline as wel…”
BackgroundInfluentialSelf-citationFortuni, F., Dietz, M. F., Prihadi, E. A., van der Bijl, P., Ferrari, G. M. D., Bax, J. J., Delgado, V., & Marsan, N. A. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.03.015 · Cited by 15
Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure
Shahim, B., Ben‐Yehuda, O., Chen, S., Redfors, B., Madhavan, M. V., Kar, S., Lim, D. S., Asch, F. M., Weissman, N. J., Cohen, D. J., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.03.011 · Cited by 15
Self-citationErrthum, R., Caballero, A., McKay, R. G., & Sun, W. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104767 · Cited by 15
Clinical Predictors of Mortality in Patients with Moderate to Severe Mitral Regurgitation
Simpson, T. F., Kumar, K., Samhan, A., Khan, O., Khan, K. R., Strehler, K. M., Fishbein, S., Wagner, L., Sotelo, M. R., Chadderdon, S. M., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.09.004 · Cited by 15
Transcatheter Edge-to-Edge Repair of Systemic Tricuspid Valve in Extracardiac Fontan Circulation
Blusztein, D. I., Moore, P., Qasim, A., Mantri, N. M., & Mahadevan, V. S. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2021.12.024 · Cited by 15
Sisinni, A., Munafò, A. R., Pivato, C. A., Adamo, M., Taramasso, M., Scotti, A., Parlati, A. L. M., Italia, L., Voci, D., Buzzatti, N., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.01.048 · Cited by 15
Felice, F. D., Paolucci, L., Musto, C., Cifarelli, A., Coletta, S., Gabrielli, D., Grasso, C., Tamburino, C., Adamo, M., Denti, P., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.07.036 · Cited by 15
Tanaka, S., Imamura, T., Narang, N., Fukuo, A., Nakamura, M., Fukuda, N., Ueno, H., & Kinugawa, K. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac370 · Cited by 15
Hosseini, K., Soleimani, H., Nasrollahizadeh, A., Jenab, Y., Karlas, A., Avgerinos, D. V., Briasoulis, Α., Kuno, T., Doulamis, I. P., & Kampaktsis, P. Ν. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103579 · Cited by 15
“Compared to medical treatment of patients with moderate-to-severe or severe secondary MR, TEER has been shown to result in a lower risk for hospitalization for heart failure or all-cause mortality [4].”
BackgroundQuentin, V., Mesnier, J., Delhomme, C., Sayah, N., Guedeney, P., Barthélémy, O., Suc, G., & Collet, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216712 · Cited by 15
“…of TEER in patients with secondary MR, particularly Second, the outcomes of TEER in patients with secondary MR, particularly those with severely altered LVEF, produced mixed results in randomized trials [37,38]. those with severely altered LVEF, produced mixed results in randomized trials [37,38].”
ResultAchieving Health Equity in the Care of Patients with Heart Failure
López, J. L. G., Duarte, G., TAYLOR, C. N., & Ibrahim, N. E. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01994-4 · Cited by 15
“Additionally, mitral valve repair has been shown to reduce HF hospitalizations and all-cause mortality in patients with HFrEF and moderate to severe secondary mitral regurgitation on maximally tolerated GDMT [77].”
Tang, G. H. L., Verma, S., & Bhatt, D. L. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0204 · Cited by 15
Single-center five-year outcomes after interventional edge-to-edge repair of the mitral valve
Öztürk, C., Friederich, M., Werner, N., Nickenig, G., Hammerstingl, C., & Schueler, R. (2019) · Cardiology Journal · doi:10.5603/cj.a2019.0071 · Cited by 15
Mitral regurgitation: lessons learned from COAPT and MITRA-Fr
Nappi, F., Nenna, A., Sing, S. S. A., Timofeeva, I., Mihos, C. G., Gentile, F., & Chello, M. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.67 · Cited by 15
Châteauneuf, G., Nazif, T. M., Beaupré, F., Kodali, S., Rodés‐Cabau, J., & Paradis, J. (2020) · Heart · doi:10.1136/heartjnl-2019-316331 · Cited by 15
Upadhyay, G. A., Henry, M. P., Genovese, D., Desai, P. V., Lattell, J., Wey, H. E., Besser, S. A., Aziz, Z. A., Beaser, A. D., Özcan, C., et al. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.07.007 · Cited by 15
Transcatheter Treatment of Mitral Regurgitation
McInerney, A., Donday, L. A. M., Tirado‐Conte, G., Hennessey, B., Espejo, C., Pozo, E., de Agustín, J. A., Gonzalo, N., Salinas, P., Nuñez-Gil, I. J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102921 · Cited by 15
Korte, G. E., Rappa, E., & Andracchi, S. (1991) · PubMed · Cited by 15
the Working Group of Interventional Cardiology of the German Society of Cardiology, Pfister, R., Hausleiter, J., Boekstegers, P., Möllmann, H., NEF, H. M., & Rudolph, V. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01457-3 · Cited by 15
Transcatheter mitral valve implantation for native valve disease
Ureña, M., Lurz, P. C., Sorajja, P., Himbert, D., & Guerrero, M. E. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00890 · Cited by 14
Medical Management and Device-Based Therapies in Chronic Heart Failure
Nguyen, A. H., Hurwitz, M., Abraham, J. A., Blumer, V. L., Flanagan, M. C., Garan, A. R., Kanwar, M. K., Kataria, R., Kennedy, J. L. W., Kochar, A., et al. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.101206 · Cited by 14
Marcoff, L., Koulogiannis, K. P., Aldaia, L., Mediratta, A., Chadderdon, S. M., Makar, M. M., Ruf, T. F., Gößler, T. A. M., Zaroff, J. G., Leung, G. K. C., et al. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.09.015 · Cited by 14
Self-citationOutcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair
Al-Abcha, A. K., Santo, P. D., Rihal, C. S., Simard, T., Hibbert, B. M., & Alkhouli, M. A. (2025) · JACC Advances · doi:10.1016/j.jacadv.2024.101541 · Cited by 14
Transcatheter Edge-to-Edge Repair for Atrial and Ventricular Secondary Mitral Regurgitation
von Stein, P., Stolz, L., Haurand, J. M., Gröger, M., Rudolph, F., Mustafa, D., Jobst, J., Mues, C. A., Mahabadi, A. A., Hoerbrand, I. A., et al. (2025) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2025.05.031 · Cited by 14
Álvarez, A. B. C., Oriol Rodríguez-leor, C., Moreno, R., & de Prado, A. P. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.10.005 · Cited by 14
“These data are consistent with those recently published the COAPT study, 42 which showed reduced rehospitalization and mortality with this technique vs optimal medical therapy in patients with functional mitral regurgitation after adequate clinical and echocardiographic selection.”
ResultStolfo, D., Castrichini, M., Biagini, E., Compagnone, M., Luca, A. D., Caiffa, T., Berardini, A., Vitrella, G., Korcova, R., Perkan, A., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12737 · Cited by 14
“in HF hospitalizations at 24 months and in the composite of death and HF hospitalization at 1 year.(8,9) One of the potential explanations for such controversy was”
BackgroundMethodResultInfluentialCardiovascular Medical Devices
Padera, R. F., & Schöen, F. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816137-1.00067-2 · Cited by 14
Functional mitral regurgitation
Asch, F. M., & Medvedofsky, D. A. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000770 · Cited by 14
Clinical Outcomes Following Urgent vs. Elective Percutaneous Mitral Valve Repair
Benito‐González, T., Estévez‐Loureiro, R., Castillo-García, S. D., Minguito‐Carazo, C., Garrote‐Coloma, C., Alonso‐Rodríguez, D., Tundidor‐Sanz, E., Rodríguez-Santamarta, M., de Prado, A. P., Ramón, C. C., et al. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.10.025 · Cited by 14
Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications
Grayburn, P. A., Packer, M., Sannino, A., & Stone, G. W. (2020) · Heart · doi:10.1136/heartjnl-2020-316992 · Cited by 14
Self-citationPatel, K., Desai, R. G., & Krishnan, S. H. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.01.003 · Cited by 14
for the EuroSMR investigators, Karam, N., Orban, M., Kalbacher, D., Butter, C., Praz, F., Lubos, E., Bannehr, M., Kassar, M., Petrescu, A. M., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01807-0 · Cited by 14
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart
Italia, L., Adamo, M., Lupi, L., Scodro, M., Curello, S., & Metra, M. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.05.013 · Cited by 14
Current Status of Transcatheter Tricuspid Valve Therapies
Romeo, J., Bashline, M. J., Fowler, J. A., Kliner, D., Toma, C., Smith, A. C., Sultan, I. S., & Sanon, S. (2022) · Heart International · doi:10.17925/hi.2022.16.1.49 · Cited by 14
Cruz‐González, I., Estévez‐Loureiro, R., Barreiro‐Pérez, M., Aguilera-Saborido, A., Olmos, C., Rincon, L. M., Gómez-Polo, J. C., Arzamendi, D., Borreguero, L., Vilacosta, I., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.05.031 · Cited by 14
İnanç, İ. H., Çilingiroğlu, M., Iliescu, C., Ninios, V. N., Matar, F., Ateş, İ., Toutouzas, K. P., Hermiller, J. B., & Marmagkiolis, K. (2022) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2022.10.005 · Cited by 16
Percutaneous Transcatheter Edge-to-Edge Mitral Valve Repair With MitraClip System in the Era of G4
Silva, I., Turgeon, P. Y., Paradis, J., Beaudoin, J., O’Connor, K., Ternacle, J., Alperi, A., Panagides, V., Mesnier, J., Gravel, C., et al. (2022) · Structural Heart · doi:10.1016/j.shj.2022.100114 · Cited by 14
Maraey, A. M., Gupta, K., Abdelmottaleb, W., Khalil, M., Ullah, W., HAJDUCZOK, A. G., Elsharnoby, H. R., Elzanaty, A., & Elgendy, I. Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101526 · Cited by 14
“01 0 (%) 1980 (6) 395 (4) 1 (%) 6310 (20) 1760 (19) 2 (%) 5765 (19) 1690 (18) 3 (%) 5590 (18) 1790 (19) 4 (%) 11,335 (37) 3545 (39) Mean CCI (SD) 2.”
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
Tomasoni, D., Adamo, M., Bozkurt, B., Heidenreich, P. A., McDonagh, T. A., Rosano, G. M. C., Virani, S., Zieroth, S. R., & Metra, M. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac124 · Cited by 14
“Both guidelines recommend optimization of GDMT in patients with severe secondary mitral regurgitation and HFrEF with surgery, in patients with an indication for concomitant coronary artery bypass surgery (CABG), and transcatheter edge–edge mitral valve repair in those patients who fulfil the COAPT (Cardiovascular Outc…”
BackgroundFelbel, D., Paukovitsch, M., Förg, R., Stephan, T., Mayer, B., Keßler, M., Tadić, M., Dahme, T., Rottbauer, W., Markovic, S., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1063070 · Cited by 14
“Shorter follow-up periods in the TEER cohort may impede comparability, however, 1-year results of TEER were repeatedly shown to be stable in the long term in randomized controlled trials (8, 9).”
MethodResultDiet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword
Rodrigues, A. A., Gonçalves, A., Morais, J., Araújo, R., & Falcão‐Pires, I. (2023) · Nutrients · doi:10.3390/nu15051223 · Cited by 14
Patient Selection for Mitral Transcatheter Edge-to-Edge Repair
Layoun, H., Harb, S. C., Krishnaswamy, A., Miyasaka, R., Yun, J. J., & Kapadia, S. R. (2023) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1199 · Cited by 14
Self-citationKourek, C., Briasoulis, Α., Papamichail, A., Xanthopoulos, A. V., Tsougos, E., Farmakis, D. T., & PARASKEVAIDIS, I. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063113 · Cited by 14
“…mitral regurgitation who remained symptomatic despite maximal medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for HF by 47% and lower all-cause mortality within 24 months of follow-up by approximately 33% compared to medical therapy alone [73].”
ResultWong, N., Hamid, N. B., Tang, H. C., & Yeo, K. K. (2018) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/yty146 · Cited by 14
Benito‐González, T., Estévez‐Loureiro, R., Garrote‐Coloma, C., Iglesias-Gárriz, I., Gualis, J., Álvarez‐Roy, L., Rodríguez-Santamarta, M., de Prado, A. P., & Fernández‐Vázquez, F. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12457 · Cited by 14
“over medical therapy in patients with FMR showed a reduction in the need for advanced HF therapies, as well as an improved survival after clip implantation.(16) Conversely, the study of Obadia et al.”
BackgroundBenito‐González, T., Estévez‐Loureiro, R., Villablanca, P. A., Armeni, P., Iglesias-Gárriz, I., Minguito, C., Garrote, C., de Prado, A. P., Tundidor‐Sanz, E., Gualis, J., et al. (2019) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2019.06.008 · Cited by 14
Crimi, G., Montalto, C., Ferri, L., Piatti, L., Bossi, I. M., Morici, N., Mirizzi, A. M., Grosseto, D., Tortorella, G., Savonitto, S., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.014 · Cited by 14
Recent advances in the treatment of chronic heart failure
Buckley, L. F., & Shah, A. M. (2019) · F1000Research · doi:10.12688/f1000research.20447.1 · Cited by 15
Doenst, T., Bargenda, S., Kirov, H., Moschovas, A., Tkebuchava, S., Safarov, R., Velichkov, I., & Diab, M. (2020) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0040-1713648 · Cited by 14
MitraClip-related infective endocarditis in a frail, elderly patient: a case report
Leow, K., Isreb, C., & Brown, M. R. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa275 · Cited by 14
Hungerford, S. L., Bart, N., Jansz, P. C., Kay, S., Emmanuel, S., Namasivayam, M. J., Dahle, G., Duncan, A., Hayward, C., & Muller, D. W. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100687 · Cited by 14
Godino, C., Sisinni, A., Pivato, C. A., Adamo, M., Taramasso, M., Parlati, A. L. M., Italia, L., Voci, D., Scotti, A., Munafò, A. R., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.043 · Cited by 14
Gómez, E. M., McInerney, A., Tirado‐Conte, G., de Agustín, J. A., Jiménez‐Quevedo, P., Escudero, A., Pozo, E., Viana‐Tejedor, A., Artaza, J. G., Marroquín, L., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29703 · Cited by 15
Prognostic Impact of Left Atrial Function Following Transcatheter Mitral Valve Repair
Ledwoch, J., Leidgschwendner, K., Fellner, C., Poch, F., Olbrich, I., Thalmann, R., Kossmann, H., Dommasch, M., Dirschinger, R. J., Stundl, A., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011727 · Cited by 14
“MR ≥2 in COAPT after 1 year.(17,18) A subanalysis of EVEREST (Endovascular Valve Edge-to-Edge Repair Study) revealed a strong correlation of the extent of LA volume reduction with the severity of residual MR.”
MethodAndreß, S., Stephan, T., Felbel, D., Mack, A., Baumhardt, M., Kersten, J., Buckert, D., Pott, A., Dahme, T., Rottbauer, W., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02032-z · Cited by 13
“In patients pending on percutaneous mitral valve repair, studies reported mortality rates of 8% after one and a half months and ≈10% after 180 days [12, 16].”
BackgroundImmune response following transcatheter aortic valve procedure
Anaraki, K. T., Zahed, Z., Javid, R. N., Shafiei, S., Beiranvandi, F., Kahrizsangi, N. G., Golafshan, F., Arzhangzadeh, A., Kojuri, J., Almassian, S., et al. (2024) · Vascular Pharmacology · doi:10.1016/j.vph.2024.107283 · Cited by 13
Antithrombotic therapy for transcatheter structural heart intervention
Guedeney, P., Rodés‐Cabau, J., ten Berg, J. M., Windecker, S., Angiolillo, D. J., Montalescot, G., & Collet, J. (2024) · EuroIntervention · doi:10.4244/eij-d-23-01084 · Cited by 13
Mitral Valve Surgery After Failed Transcatheter Edge-to-Edge Repair: A Meta-Analysis
Cabrucci, F., Baudo, M., Magouliotis, D. E., Yamashita, Y., Kjelstrom, S., Bacchi, B., Bonacchi, M., Dokollari, A., Sicouri, S., & Ramlawi, B. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.02.010 · Cited by 13
Chioncel, O. D., Savarese, G., Laroche, C., Amir, O., Tokmakova, M. P., Cannata, A. N., Do, D. L., Kafafy, T. A., Krejčí, J., Moura, B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70065 · Cited by 13
Heart Failure With Mildly Reduced Ejection Fraction
Wu, L., Rizwan, A. M., Rodriguez, M., Hachem, K. E., Virk, H. U. H., Khawaja, M., Strauß, M., & Krittanawong, C. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102476 · Cited by 13
Perpetua, E. M., Clarke, S. E., Guibone, K. A., Keegan, P. A., & Speight, M. K. (2019) · Structural Heart · doi:10.1080/24748706.2019.1581962 · Cited by 13
Oikawa, M., Yoshihisa, A., Sato, Y., Nagai, T., Yoshikawa, T., Saito, Y., Yamamoto, K., Takeishi, Y., & Anzai, T. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01581-5 · Cited by 13
Average pixel intensity method for prediction of outcome in secondary mitral regurgitation
Kamoen, V., Buyzere, M. D., Haddad, M. E., Backer, T. L. M. D., & Timmermans, F. (2020) · Heart · doi:10.1136/heartjnl-2019-316157 · Cited by 13
“In SMR, the altered geometry of mitral valve coaptation and the elliptical regurgitant orifice area may cause flattening of the flow convergence zone and underestimation of PISA-EROA calculation.”
InfluentialIliadis, C., Metze, C., Körber, M. I., Baldus, S. E., & Pfister, R. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12778 · Cited by 13
“Furthermore, two recent randomized controlled trials in highly selected patients with functional MR also showed inconsistent results both regarding prognostic and symptomatic benefit in comparison with standard heart failure therapy.(4,5) The underlying causes for this effect heterogeneity are largely unclear so far a…”
BackgroundTyler, J., Narbutas, R., Oakley, L. S., Ebinger, J. E., & Nakamura, M. (2020) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2020.07.001 · Cited by 13
“Percutaneous mitral valve repair with MitraClip (Abbot Vascular, Menlo Park, CA, USA) is an established therapy for treatment of degenerative MR and functional MR [3,4].”
Multimodality Imaging in Secondary Mitral Regurgitation
Sharma, H. C., Liu, B., Mahmoud-Elsayed, H. M., Myerson, S. G., & Steeds, R. P. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.546279 · Cited by 13
“COAPT, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation; MITRA-FR, Percutaneous Repair or Medical Treatment for SecondaryMitral Regurgitation; GDMT, Guideline Directed Medical Therapy; EROA, Effective Regurgitant Orifice Area; LVEF…”
BackgroundInfluentialKhan, M. S., Siddiqi, T. J., Butler, J., Friede, T., Levy, W. C., Witte, K. K., Lipiecki, J., Sievert, H., & Coats, A. J. S. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13273 · Cited by 13
Spring, A. M., Catalano, M. A., Rutkin, B. J., Hartman, A., & Yu, P. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15735 · Cited by 13
Kato, N., Thaden, J. J., Miranda, W. R., Scott, C. G., Enriquez-Sarano, M. L., Greason, K. L., & Pellikka, P. A. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13649 · Cited by 13
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.